Loading...
First Round of Abstract Submission Ends: Nov 30, 2026
Extended Early Bird Ends: Apr 28, 2026

Programme Overview

Titles Accepted for Presentations

Plenary Talks

Zhiling YU, Hong Kong Baptist University, China

Metabolic Reprogramming and Mitochondrial Dysfunction as Therapeutic Targets in Toxicology and Disease

 
Douglas B. Kell, University of Liverpool, UK

How Drugs Really Get Into Cells: Why Passive Bilayer Diffusion is a Myth

 
Ülo Langel, Stockholm University, Sweden

Cell-penetrating peptides for new pharmacology

 
Thomas J. Webster, Brown University, USA

Using Nanomedicine, Not Drugs, To Improve Mobility In Over 45,000 Patients

 
Fabian Kiessling, RWTH Aachen University, Germany

Imaging-Guided Precision Oncology

 
Hyung Sik Kim, Sungkyunkwan University, Korea

Metabolic Reprogramming and Mitochondrial Dysfunction as Therapeutic Targets in Toxicology and Disease

 
Paola Patrignani, “G. d’Annunzio” University, Italy

Current concepts and innovative targets in antiplatelet therapy for disease prevention, treatment, and diagnostics, advancing precision medicine

 
Flemming Cassee, RIVM, trecht University, Netherlands

Where do inhaled particles go upon inhalation and what is their health impact?

 
Cidlowski, John, North caroline University, Chapel Hill

Nuclear Receptor Interactome.novel actions of these receptors

 
Brian S. J. Blagg, The University of Notre Dame, USA

Targeting Chaperones for the Treatment of Cancer, Neurodegeneration, and Glaucoma

 
Sibel A. Ozkan, Ankara University,Türkiye

Toxicological Targets: The Role of Molecularly Imprinted Polymers in Real-Time Analysis

 
Andrzej Pilc, Jagiellonian University, Poland

Interactions between hallucinogenic antidepressants and mGlu2/3 receptor ligands as a potential strategy to increase the effectiveness of antidepressant therapy.

 
Godefridus Peters, University of Gdansk, Poland

How to tackle drug resistance in pancreatic cancer

 

Keynote Talks

Karla Neves, University of Strathclyde, UK

Decoding Vascular Injury in Cancer Therapy: A Molecular and Cellular Perspective

 
Ismail Murat Palabiyik, University of Ankara, Turkey

Sustainable Pharmaceutical Analysis in Drug Development and Safety: From Green Chemistry to Intelligent Analytical Platforms

 
Samuel CONSTANT, CEO, Epithelix Sàrl, Switzerland

Immunocompetent in vitro airway models as decision-making tools for pharmacology and toxicology research

 
Miroslav Radenković, University of Belgrade, Serbia

Biopharmaceuticals – Current Standing

 
Eugene Zadorin, Director of NBScience, UK

Cellular Regeneration Revolution: Advancing Stem Cell Therapies from Research to Clinical Applications

 
Barbara Chruścicka-Smaga, Polish Academy of Sciences, Poland

The effects of serotonin receptors and metabotropic glutamate receptors cross-talk on psilocybin-induced antidepressant-like effects

 
Bernadeta Szewczyk, Polish Academy of Sciences, Poland

Zinc and Magnesium as Modulators of Antidepressant Mechanisms: Neurobiological Basis and Therapeutic Potential of Antidepressant–Metal Complexes

 
Repson Maria, University of Zurich, Switzerland

Massive parallelized gene therapy development leveraging natural evolution processes

 
Yizhun Zhu, Macau University of Science and Technology, China

Molecular pharmacology and new target drug discovery: bench to bedside

 
Roberto Avola, University of Catania, Italy

Effects of lipoic acid and choline alphoscerate (a well-known cholinergic drug) during astroglial cell proliferation and differentiation in primary cultures

 
Sreenivasan Sasidharan, Universiti Sains Malaysia, Malaysia

Green Carbon Dots from Agro-Waste: A Sustainable Path to Anticancer Nanotechnology

 
Wolfgang Scholz, TU Dortmund University, Germany

The international 5-Decades-Drug-Safety-Travel with SCHOLZ DataBank

 
C. Arsene, University of Iasi, Romania

A WhyWhatWhom Concept Applied in a Critical Introspection of the Analytical Measurements Accuracy Role in Linking Chemical Management to the Nowadays SDGs. A Perspective from the Recent Air State

 

Invited Talks

Samaa Abdullah, Applied Science Private University, Jordan

Redox-Modulating Glutathione Nanogel for Acute Wound Therapy

 
JUN JI, Fuwai Hospital, Chinese Academy of Medical Sciences, Shenzhen, China

Metabolic & Endocrine Pharmacology

 
Krathish Bopanna, Kidney Injury, University of Technology, China

Translational Challenges and Emerging Strategies in Pharmacology: Bridging Bench Research to Clinical Practice

 
ben friday, Spartanburg Medical Center, South Carolina

In Silico Design and Evaluation of Novel Geniposide Derivatives as Potential GLP-1 Receptor Agonists for the Management of Type 2 Diabetes

 
Galila Agam, University of the Negev, Beer-Sheva, Israel

sex differences and their consequences in bipolar disorder

 
Samaa Abdullah, Applied Science Private University, Jordan

Redox-Modulating Glutathione Nanogel for Acute Wound Therapy

 
Qian Zhang, The Third Affiliated Hospital of Nanjing Medical University, China

Inflammatory Effects in COPD: Targeting Oxidative Stress and CD8⁺ T Cell Cytotoxicity

 
Jürgen Dietrich, TU Dortmund University, Germany

Pharmacogenomic Knowledge Graph Augmentation for Graph Neural Network-Based Drug-Drug Interaction Prediction

 
Abubakar Amali Muhammad, Usmanu Danfodiyo University, Nigeria

Molecular Docking Approach of (+)-Catechin-3’-O-Rhamnopyranoside Compound from Neocarya macrophylla plant interacting with Erythropoietin Target Receptor